Charles Schwab’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $69.6M | Buy |
688,264
+497
| +0.1% | +$51.5K | 0.01% | 1015 |
|
|
2026
Q1 | $66.5M | Buy |
687,767
+7,368
| +1% | +$756K | 0.01% | 965 |
|
|
2025
Q4 | $72.2M | Sell |
680,399
-15,097
| -2% | -$1.75M | 0.01% | 910 |
|
|
2025
Q3 | $88.3M | Sell |
695,496
-2,557
| -0.4% | -$304K | 0.01% | 790 |
|
|
2025
Q2 | $85.6M | Buy |
698,053
+12,476
| +2% | +$1.42M | 0.01% | 746 |
|
|
2025
Q1 | $69.4M | Buy |
685,577
+40,813
| +6% | +$3.98M | 0.01% | 848 |
|
|
2024
Q4 | $59.5M | Buy |
644,764
+4,345
| +0.7% | +$427K | 0.01% | 1003 |
|
|
2024
Q3 | $61.9M | Sell |
640,419
-517
| -0.1% | -$46.5K | 0.01% | 959 |
|
|
2024
Q2 | $55M | Buy |
640,936
+3,084
| +0.5% | +$259K | 0.01% | 998 |
|
|
2024
Q1 | $52.7M | Buy |
637,852
+6,036
| +1% | +$442K | 0.01% | 1009 |
|
|
2023
Q4 | $42.2M | Buy |
631,816
+12,396
| +2% | +$803K | 0.01% | 1115 |
|
|
2023
Q3 | $41.6M | Buy |
619,420
+56
| +0% | +$3.85K | 0.01% | 1008 |
|
|
2023
Q2 | $41.9M | Sell |
619,364
-2,809
| -0.5% | -$176K | 0.01% | 974 |
|
|
2023
Q1 | $33.7M | Buy |
622,173
+598
| +0.1% | +$34.8K | 0.01% | 1102 |
|
|
2022
Q4 | $37.2M | Buy |
621,575
+23,080
| +4% | +$1.26M | 0.01% | 997 |
|
|
2022
Q3 | $27.1M | Sell |
598,495
-131,601
| -18% | -$6.58M | 0.01% | 1168 |
|
|
2022
Q2 | $32.6M | Buy |
730,096
+12,651
| +2% | +$649K | 0.01% | 1043 |
|
|
2022
Q1 | $40.6M | Buy |
717,445
+31,397
| +5% | +$1.64M | 0.01% | 1019 |
|
|
2021
Q4 | $35.6M | Buy |
686,048
+24,244
| +4% | +$1.25M | 0.01% | 1138 |
|
|
2021
Q3 | $39.5M | Buy |
661,804
+21,058
| +3% | +$1.32M | 0.01% | 1036 |
|
|
2021
Q2 | $39.8M | Buy |
640,746
+21,122
| +3% | +$1.41M | 0.01% | 1037 |
|
|
2021
Q1 | $40.4M | Sell |
619,624
-11,036
| -2% | -$720K | 0.01% | 975 |
|
|
2020
Q4 | $41.5M | Buy |
630,660
+8,006
| +1% | +$471K | 0.02% | 891 |
|
|
2020
Q3 | $32.2M | Sell |
622,654
-27,196
| -4% | -$1.4M | 0.01% | 907 |
|
|
2020
Q2 | $32M | Buy |
649,850
+16,008
| +3% | +$864K | 0.02% | 852 |
|
|
2020
Q1 | $32.3M | Buy |
633,842
+23,760
| +4% | +$1.37M | 0.02% | 699 |
|
|
2019
Q4 | $33.6M | Buy |
610,082
+10,342
| +2% | +$561K | 0.02% | 872 |
|
|
2019
Q3 | $30.2M | Buy |
599,740
+16,983
| +3% | +$853K | 0.02% | 889 |
|
|
2019
Q2 | $29.4M | Buy |
582,757
+19,265
| +3% | +$935K | 0.02% | 879 |
|
|
2019
Q1 | $26.2M | Sell |
563,492
-122,170
| -18% | -$6.19M | 0.02% | 942 |
|
|
2018
Q4 | $33.7M | Sell |
685,662
-47,564
| -6% | -$2.71M | 0.03% | 636 |
|
|
2018
Q3 | $45.5M | Sell |
733,226
-178,853
| -20% | -$10.9M | 0.03% | 579 |
|
|
2018
Q2 | $49.1M | Sell |
912,079
-112,543
| -11% | -$5.62M | 0.04% | 510 |
|
|
2018
Q1 | $46.6M | Buy |
1,024,622
+42,799
| +4% | +$1.83M | 0.04% | 512 |
|
|
2017
Q4 | $38.6M | Sell |
981,823
-5,015
| -0.5% | -$191K | 0.03% | 571 |
|
|
2017
Q3 | $36.4M | Buy |
986,838
+143,009
| +17% | +$5.1M | 0.03% | 548 |
|
|
2017
Q2 | $32.5M | Buy |
843,829
+42,782
| +5% | +$1.57M | 0.03% | 557 |
|
|
2017
Q1 | $27.3M | Buy |
801,047
+110,765
| +16% | +$3.64M | 0.03% | 625 |
|
|
2016
Q4 | $22.6M | Buy |
690,282
+36,597
| +6% | +$1.19M | 0.02% | 679 |
|
|
2016
Q3 | $21.1M | Buy |
653,685
+139,852
| +27% | +$4.53M | 0.02% | 654 |
|
|
2016
Q2 | $15.9M | Sell |
513,833
-660
| -0.1% | -$20.6K | 0.02% | 777 |
|
|
2016
Q1 | $15.4M | Buy |
514,493
+20,616
| +4% | +$569K | 0.02% | 771 |
|
|
2015
Q4 | $13.7M | Buy |
493,877
+31,418
| +7% | +$894K | 0.02% | 834 |
|
|
2015
Q3 | $14.1M | Buy |
462,459
+18,767
| +4% | +$653K | 0.02% | 744 |
|
|
2015
Q2 | $16.3M | Buy |
443,692
+8,961
| +2% | +$320K | 0.02% | 678 |
|
|
2015
Q1 | $15.3M | Buy |
434,731
+34,182
| +9% | +$1.17M | 0.02% | 713 |
|
|
2014
Q4 | $12.3M | Buy |
400,549
+64,085
| +19% | +$2M | 0.02% | 757 |
|
|
2014
Q3 | $9.88M | Buy |
336,464
+4,852
| +1% | +$148K | 0.02% | 847 |
|
|
2014
Q2 | $9.46M | Buy |
331,612
+2,159
| +0.7% | +$60.2K | 0.02% | 886 |
|
|
2014
Q1 | $9.42M | Sell |
329,453
-19,465
| -6% | -$507K | 0.02% | 848 |
|
|
2013
Q4 | $9.25M | Buy |
348,918
+15,803
| +5% | +$440K | 0.02% | 776 |
|
|
2013
Q3 | $9.3M | Buy |
333,115
+10,016
| +3% | +$257K | 0.02% | 681 |
|
|
2013
Q2 | $7.6M | Buy |
+323,099
| New | +$7.3M | 0.02% | 722 |
|
Other funds holding EHC
Charles Schwab's EHC Position: Q2 2026 in Review
Charles Schwab increased its Encompass Health (EHC) stake by 0.07% in Q2 2026, buying an estimated $51.5K and bringing the position to 688,264 shares worth $69.6M. The position accounts for 0.01% of the portfolio, ranked #1015.
Charles Schwab first reported a position in EHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $88.3M in Q3 2025. 595 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- Charles Schwab held 688,264 shares of Encompass Health worth $69.6M as of Q2 2026.
- Charles Schwab bought 497 Encompass Health shares in Q2 2026, an estimated $51.5K.
- Encompass Health made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1015 holding.
- Charles Schwab first reported a position in Encompass Health in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Encompass Health position peaked at $88.3M in Q3 2025.
- 595 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.